Growth Metrics

Voyager Therapeutics (VYGR) Net Income Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Voyager Therapeutics 230.25 Mn 88.77 Mn - 9.94%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.94%
Dec 31, 2025 20.47%
Sep 30, 2025 -208.40%
Jun 30, 2025 -229.18%
Mar 31, 2025 -173.80%
Dec 31, 2024 -161.15%
Sep 30, 2024 65.08%
Jun 30, 2024 54.34%
Mar 31, 2024 -109.13%
Dec 31, 2023 338.86%
Sep 30, 2023 -246.96%
Jun 30, 2023 -16.35%
Mar 31, 2023 681.85%
Dec 31, 2022 -566.69%
Sep 30, 2022 170.43%
Jun 30, 2022 33.11%
Mar 31, 2022 16.62%
Dec 31, 2021 121.39%
Sep 30, 2021 -129.52%
Jun 30, 2021 -230.48%
Mar 31, 2021 -9.02%
Dec 31, 2020 -88.07%
Sep 30, 2020 664.98%
Jun 30, 2020 -177.42%
Mar 31, 2020 13.67%
Dec 31, 2019 44.19%
Sep 30, 2019 26.04%
Jun 30, 2019 143.67%
Mar 31, 2019 -36.35%
Dec 31, 2018 -90.97%
Sep 30, 2018 13.09%
Jun 30, 2018 -35.31%
Mar 31, 2018 -19.69%
Dec 31, 2017 19.59%
Sep 30, 2017 -159.52%
Jun 30, 2017 -102.21%
Mar 31, 2017 -131.61%
Dec 31, 2016 -101.47%
Sep 30, 2016 -129.67%
Jun 30, 2016 -144.24%
Mar 31, 2016 50.69%
Dec 31, 2015 -55.29%
Sep 30, 2015 2.20%